Full-Time

Sr. Manager Information Systems

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Full-Stack Engineering
Software Engineering
Requirements
  • Doctorate Degree and 2 years of experience in Engineering, IT or related field OR
  • Master’s degree with 8 - 10 years of experience in Engineering, IT or related field OR
  • Bachelor’s degree with 10 - 14 years of experience in Engineering, IT or related field OR
  • Diploma with 14 - 18 years of experience in Engineering, IT or related field
  • Background as a Technical Product Owner (TPO), people manager, and business analyst
  • Proven leadership skills with the ability to lead large matrixed teams
  • Experience in implementing a strategic roadmap and driving transformation initiatives using Scaled Agile methodology
  • Strong skills in collaborating and communicating with cross-functional teams, business collaborators, and executives
  • Degree in Computer Science, Information Systems, Engineering, or Life Sciences.
Responsibilities
  • Maintain strategic relationships and strong communication with the leadership team
  • Oversee the software development lifecycle, ensuring standard methodologies in development, testing, and deployment
  • Lead and handle large teams with varied strengths within a matrixed organization
  • Develop and implement strategic plans for technology and workforce growth
  • Developing talent, motivating the team, delegating effectively, championing diversity within the team
  • Ensuring global ways of working are embedded in the local organization
  • Develop a culture of collaboration, innovation, and continuous improvement
  • Fostering standard methodology sharing and alignment with business goals
  • Collaborate with Platform Owners, Product Owners, Service Owners, and delivery teams
  • Participate in team member and leadership meetings
  • Remain accountable for ensuring overall organizational compliance with quality and GxP in technology services
  • Monitor emerging technologies and trends to find opportunities for platform growth and expansion
  • Ensure ongoing alignment with strategy, compliance, and regulatory requirements for technology investments and services.
Desired Qualifications
  • At least 5 – 8 years of domain knowledge in health and/or life sciences combined with Information Technology
  • Understanding, and preferably applied experience and knowledge, in data management and CTD document drafting
  • Leadership experience within a highly regulated pharmaceutical or technology organization
  • Experience driving a collaborative culture that values technical depth, accountability, and customer service
  • Strong problem-solving and analytical skills
  • Demonstrated ability to work effectively in a fast-paced, dynamic environment
  • Understanding of ITIL processes and implementation
  • Experience handling vendor relationships and working with external partners or consultants.

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.